Literature DB >> 10515456

Adenovirus-mediated suicide gene transduction: feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits.

F Malecaze1, B Couderc, S de Neuville, B Serres, J Mallet, V Douin-Echinard, S Manenti, F Revah, J M Darbon.   

Abstract

The most common complication of cataract surgery is the development of posterior capsule opacification (PCO). Hyperplasia of the lens epithelium is one of the main cellular events following phacoemulsification, and has been found to be an important feature contributing to opacification of the posterior capsule. Adenoviral vector-mediated transfer is a suitable method for transducing the herpes simplex virus thymidine kinase gene (HSV-tk) into proliferating cells, allowing for the selective killing of these cells by ganciclovir (GCV) treatment. To determine the potential of gene transduction for lens epithelial cells, we studied the transduction of rabbit lens epithelial cells with adenoviral vectors containing either the Escherichia coli beta-galactosidase (lacZ) gene or the HSV-tk gene in vitro and in vivo in an experimental model of PCO. The efficiency of lacZ gene transfer in rabbit lens epithelial cells was at least 95% both in vitro and in vivo. In vivo transduction with HSV-tk adenoviral vector followed by GCV treatment significantly inhibited the development of PCO (p<0.001). These results suggest that adenoviral vector-mediated transfer of HSV-tk into the proliferating lens epithelial cells is feasible and may provide a novel therapeutic strategy for PCO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515456     DOI: 10.1089/10430349950017013

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

1.  Systems of analysis of posterior capsule opacification.

Authors:  T M Aslam; B Dhillon; N Werghi; A Taguri; A Wadood
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

Review 2.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

3.  Influence of super-hydrophobic silicone rubber substrate on the growth and differentiation of human lens epithelial cells.

Authors:  Liuxueying Zhong; Jiayi Jin; Danying Zheng; Weisheng Guan; Yue Guo; Anfu Chen; Yujiang Peng; Qianying Gao; Yongxin Zheng; Hanxiong Huang
Journal:  J Mater Sci Mater Med       Date:  2018-11-13       Impact factor: 3.896

4.  Inhibition of proliferation of rabbit lens epithelial cells by S-phase kinase-interacting protein 2 targeting small interfering RNA.

Authors:  Ying Su; Feng Wang; Qinghui Yan; Yan Teng; Hao Cui
Journal:  Mol Vis       Date:  2010-05-25       Impact factor: 2.367

5.  ATRA enhances the bystander effect of suicide gene therapy driven by the specific promoter LEP 503 in human lens epithelial cells.

Authors:  Jin Yang; Tian-Jin Liu; Yong-Xiang Jiang; Yi Lu
Journal:  Mol Vis       Date:  2012-07-25       Impact factor: 2.367

6.  Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.

Authors:  Yong-Xiang Jiang; Yi Lu; Tian-Jing Liu; Jin Yang; Yan Chen; Yan-Wen Fang
Journal:  Mol Vis       Date:  2011-01-27       Impact factor: 2.367

7.  The polyamidoamine-mediated inhibition of bcl-2 by small hairpin RNA to induce apoptosis in human lens epithelial cells.

Authors:  Xin-Hua Wu; Yi Lu; Yan-Wen Fang; Yong-Xiang Jiang
Journal:  Mol Vis       Date:  2012-01-12       Impact factor: 2.367

8.  Downregulation of transforming growth factor-β type II receptor prohibit epithelial-to-mesenchymal transition in lens epithelium.

Authors:  Danying Zheng; Tingting Song; Xueying Zhongliu; Mingxing Wu; Jingli Liang; Yizhi Liu
Journal:  Mol Vis       Date:  2012-05-11       Impact factor: 2.367

9.  Methods of assessment of patients for Nd:YAG laser capsulotomy that correlate with final visual improvement.

Authors:  Tariq M Aslam; Niall Patton
Journal:  BMC Ophthalmol       Date:  2004-09-23       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.